OMRF researchers found mutations in PDGF receptor beta can trigger two rare diseases.
New findings could help scientists develop treatments for the condition known as ITP.
QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Abnormal numbers of chromosomes—known as aneuploidy—are a common cause of genetic disorders and birth defects.
An enzyme called PP1 tells the cells it’s the right time to divide.
OMRF researchers another step in translational medicine.